Anne L. Holleran

Array ( [id] => 5112929 [patent_doc_number] => 20070196844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Protein PDX1 as a marker for breast cancer' [patent_app_type] => utility [patent_app_number] => 11/640523 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10468 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196844.pdf [firstpage_image] =>[orig_patent_app_number] => 11640523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286416 [patent_doc_number] => 08642745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Method for making multispecific antibodies having heteromultimeric and common components' [patent_app_type] => utility [patent_app_number] => 11/608673 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 29977 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11608673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309707 [patent_doc_number] => 20090016988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Modified Pore-Forming Protein Toxins and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/094597 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 41211 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20090016988.pdf [firstpage_image] =>[orig_patent_app_number] => 12094597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4972176 [patent_doc_number] => 20070112179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 11/594126 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9749 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20070112179.pdf [firstpage_image] =>[orig_patent_app_number] => 11594126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183015 [patent_doc_number] => 20070054362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Recombinant production of mixtures of antibodies' [patent_app_type] => utility [patent_app_number] => 11/593280 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 33529 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054362.pdf [firstpage_image] =>[orig_patent_app_number] => 11593280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710611 [patent_doc_number] => 20080299137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Fusion Proteins That Bind Effector Lymphocytes And Target Cells' [patent_app_type] => utility [patent_app_number] => 12/091820 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 35191 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299137.pdf [firstpage_image] =>[orig_patent_app_number] => 12091820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216131 [patent_doc_number] => 08628931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'mTOR pathway theranostic' [patent_app_type] => utility [patent_app_number] => 12/083866 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13383 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12083866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 52723 [patent_doc_number] => 07771958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Method for predicting response to epidermal growth factor receptor-directed therapy' [patent_app_type] => utility [patent_app_number] => 11/548386 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6589 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771958.pdf [firstpage_image] =>[orig_patent_app_number] => 11548386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4474020 [patent_doc_number] => 07867717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Immunoassays to detect diseases or disease susceptibility traits' [patent_app_type] => utility [patent_app_number] => 11/545660 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19235 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/867/07867717.pdf [firstpage_image] =>[orig_patent_app_number] => 11545660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4982385 [patent_doc_number] => 20070086943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'EphA2 agonistic monoclonal antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/544332 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 36532 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20070086943.pdf [firstpage_image] =>[orig_patent_app_number] => 11544332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549080 [patent_doc_number] => 20100222416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Diagnostic Marker and Therapeutic Target for Cancer' [patent_app_type] => utility [patent_app_number] => 12/083366 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5050 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222416.pdf [firstpage_image] =>[orig_patent_app_number] => 12083366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204521 [patent_doc_number] => 20070026001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'APO-2 ligand-anti-her-2 antibody synergism' [patent_app_type] => utility [patent_app_number] => 11/540701 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14828 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026001.pdf [firstpage_image] =>[orig_patent_app_number] => 11540701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4628917 [patent_doc_number] => 08007799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Vascular endothelial cell growth factor antagonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/536871 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 15059 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007799.pdf [firstpage_image] =>[orig_patent_app_number] => 11536871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9574999 [patent_doc_number] => 08765412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Method for making multispecific antibodies having heteromultimeric and common components' [patent_app_type] => utility [patent_app_number] => 11/536951 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 29986 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11536951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5507988 [patent_doc_number] => 20090081195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility' [patent_app_type] => utility [patent_app_number] => 12/067844 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18750 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081195.pdf [firstpage_image] =>[orig_patent_app_number] => 12067844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101261 [patent_doc_number] => 20070184523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components' [patent_app_type] => utility [patent_app_number] => 11/536439 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28350 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184523.pdf [firstpage_image] =>[orig_patent_app_number] => 11536439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242215 [patent_doc_number] => 20070020710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Antibodies that spefically recognize inactive PSA, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/525990 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5840 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020710.pdf [firstpage_image] =>[orig_patent_app_number] => 11525990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074800 [patent_doc_number] => 20070014775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 11/533199 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 21472 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014775.pdf [firstpage_image] =>[orig_patent_app_number] => 11533199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074799 [patent_doc_number] => 20070014774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 11/533184 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 21472 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014774.pdf [firstpage_image] =>[orig_patent_app_number] => 11533184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5241769 [patent_doc_number] => 20070020261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Combination therapy of her expressing tumors' [patent_app_type] => utility [patent_app_number] => 11/490438 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 55861 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020261.pdf [firstpage_image] =>[orig_patent_app_number] => 11490438 [rel_patent_id] =>[rel_patent_doc_number] =>)